{"title":"新的抗逆转录病毒药物上市:2017年Croi药理学新闻","authors":"N. Hentig","doi":"10.4172/1948-5964.1000e140","DOIUrl":null,"url":null,"abstract":"The Conference on Retrovirus and Opportunistic Infections, CROI, 2017 at Seattle, USA, presented several new substances, therapy strategies and other data about the treatment of HIV/AIDS. The following article discusses a pharmacological selection of these, and shows data of new integrase inhibitors (INSTI), nucleoside (NRTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) as well as protease inhibitors (PI), CCR5-inhibitors and several long-acting antibodies or new formulations of already widely used drugs, such as Nano particle PI and NNRTI (NANO-NNRTI, NANO-PI).","PeriodicalId":15020,"journal":{"name":"Journal of Antivirals & Antiretrovirals","volume":"1 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Antiretrovirals on the Block: Pharmacological news from Croi 2017\",\"authors\":\"N. Hentig\",\"doi\":\"10.4172/1948-5964.1000e140\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Conference on Retrovirus and Opportunistic Infections, CROI, 2017 at Seattle, USA, presented several new substances, therapy strategies and other data about the treatment of HIV/AIDS. The following article discusses a pharmacological selection of these, and shows data of new integrase inhibitors (INSTI), nucleoside (NRTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) as well as protease inhibitors (PI), CCR5-inhibitors and several long-acting antibodies or new formulations of already widely used drugs, such as Nano particle PI and NNRTI (NANO-NNRTI, NANO-PI).\",\"PeriodicalId\":15020,\"journal\":{\"name\":\"Journal of Antivirals & Antiretrovirals\",\"volume\":\"1 1\",\"pages\":\"1-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Antivirals & Antiretrovirals\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/1948-5964.1000e140\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antivirals & Antiretrovirals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/1948-5964.1000e140","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
New Antiretrovirals on the Block: Pharmacological news from Croi 2017
The Conference on Retrovirus and Opportunistic Infections, CROI, 2017 at Seattle, USA, presented several new substances, therapy strategies and other data about the treatment of HIV/AIDS. The following article discusses a pharmacological selection of these, and shows data of new integrase inhibitors (INSTI), nucleoside (NRTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) as well as protease inhibitors (PI), CCR5-inhibitors and several long-acting antibodies or new formulations of already widely used drugs, such as Nano particle PI and NNRTI (NANO-NNRTI, NANO-PI).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
